Percentage of Participants With Improvement of Greater Than or Equal to [≥]5 Milliliters Per Minute Per 1.73 Square Meters (mL/Min/m^2) in Calculated Glomerular Filtration Rate (GFR) at 24 Months Post-Transplantation (On-Therapy Analysis) [clinicaltrials_resource:NCT00895583/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Percentage of Participants With Improvement of Greater Than or Equal to [≥]5 Milliliters Per Minute Per 1.73 Square Meters (mL/Min/m^2) in Calculated Glomerular Filtration Rate (GFR) at 24 Months Post-Transplantation (On-Therapy Analysis) [clinicaltrials_resource:NCT00895583/outcome/1]
Bio2RDF identifier
NCT00895583/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00895583/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
ITT Population
ITT Population. Missing GFR wa ...... ination or skipped assessment.
ITT Population: all randomized ...... ination or skipped assessment.
On-Therapy Population (12 Mont ...... 2 months post-transplantation.
On-Therapy Population (24 Mont ...... 4 months post-transplantation.
On-Therapy Population: all par ...... ed parameter at a given visit.
On-Therapy Population: all par ...... ed parameter at a given visit.
On-Therapy Population; n=numbe ...... ed parameter at a given visit.
On-Therapy analysis of the slo ...... re excluded from the analysis.
Safety Population
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
12 Months and 24 Months
Baseline and Months 12 and 24
Baseline, Month 12
Baseline, Month 24
Baseline, Months 12 and 24
Baseline, Months 6, 12, 18, and 24
From Baseline to On-Therapy Mo ...... h 12 up to On-Therapy Month 24
From randomization up to 24 months after transplantation (On-Therapy)
Months 12 and 24
Months 6, 12, 18, and 24
type [clinicaltrials_vocabulary:type]
alternate
Percentage of Participants Wit ...... antation (On-Therapy Analysis)
@en
identifier
clinicaltrials_resource:NCT00895583/outcome/1
title
GFR was calculated using the M ...... atinine not traceable to IDMS.
@en
type
label
Percentage of Participants Wit ...... esource:NCT00895583/outcome/1]
@en